See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
UnitedHealth Group Incorporated (UNH) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group Incorporated (UNH) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for January 23rd
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 23rd:
Bio-Techne Corporation (TECH - Free Report) : This manufacturer of biotechnology reagents has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 0.5% over the last 60 days.
Bio-Techne Corp Price and Consensus
Bio-Techne Corp Price and Consensus | Bio-Techne Corp Quote
Bio-Techne’s shares gained 9.9% over the last one month more than S&P 500’s gain of 5.6%. The company possesses a Momentum Score of A.
Bio-Techne Corp Price
Bio-Techne Corp Price | Bio-Techne Corp Quote
UnitedHealth Group Incorporated (UNH - Free Report) : This diversified health company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 14.3% over the last 60 days.
UnitedHealth Group Incorporated Price and Consensus
UnitedHealth Group Incorporated Price and Consensus | UnitedHealth Group Incorporated Quote
UnitedHealth Group’s shares gained 10.7% over the last one month. The company possesses a Momentum Score of A.
UnitedHealth Group Incorporated Price
UnitedHealth Group Incorporated Price | UnitedHealth Group Incorporated Quote
Fibrocell Science, Inc. : This gene therapy company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 36.8% over the last 60 days.
Fibrocell Science Inc Price and Consensus
Fibrocell Science Inc Price and Consensus | Fibrocell Science Inc Quote
Fibrocell Science’s shares gained 14.5% over the last one month. The company possesses a Momentum Score of B.
Fibrocell Science Inc Price
Fibrocell Science Inc Price | Fibrocell Science Inc Quote
Boot Barn Holdings, Inc. (BOOT - Free Report) : This lifestyle retail chain operator has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 13.6% over the last 60 days.
Boot Barn Holdings, Inc. Price and Consensus
Boot Barn Holdings, Inc. Price and Consensus | Boot Barn Holdings, Inc. Quote
Boot Barn Holdings’ shares gained 9.1% over the last one month. The company possesses a Momentum Score of A.
Boot Barn Holdings, Inc. Price
Boot Barn Holdings, Inc. Price | Boot Barn Holdings, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>